← SynDRA
SCH-23390
SynDRA canonical compound SYN0000319 — structure-anchored drug synonym record
| Clinical phase | Preclinical |
|---|
| Primary target(s) | HTR2C |
|---|
| Mechanism of action | Dopamine receptor antagonist |
|---|
All known targets
- DRD1
- DRD5
- HTR2C
- KCNJ4
- KCNJ6
Mechanisms of action (all sources)
- Dopamine receptor antagonist
- DRD1 ANTAGONIST
Bioactivity evidence (ChEMBL activities table — not curator-asserted)
- DRD3
- ADRB2
- GPR183
- GPR119
- APLNR
- GLP1R
- CX3CR1
- SIGMAR1
- FFAR4
- DRD2
- ADGRF1
- MPG
- MUTYH
- NEIL1
- NEIL2
- NTHL1
- PTH1R
- OGG1
- HSD17B10
- RGS4
- S1PR1
- TDG
- TDP1
- TSHR
- UGT2B15
- UNG
- MBD4
- GMNN
- HDAC6
- GPR35
- AGTR1
- ALOX15
- APEX1
- ATXN2
- C5AR1
- CYP1A2
- CYP2C19
- CYP2C9
- CYP2D6
- CYP3A4
Cross-references
Synonyms
- Sch-23388
- Lopac-D-054
- AC1O7G1X
- GTPL956
- CHEMBL63321
- SCH 23388 (S-enantiomer)
- SCHEMBL11107859
- BDBM82248
- GOTMKOSCLKVOGG-HNNXBMFYSA-N
- ZINC2017840
- PDSP1_001624
- PDSP2_001608
- PDSP2_000613
- PDSP1_000616
- NCGC00015301-01
- (+)-SCH-23390
- CAS_73445-63-3
- (5S)-8-chloro-3-methyl-5-phenyl-1,2,4,5-tetrahydro-3-benzazepin-7-ol
- (1S)-7-chloro-3-methyl-1-phenyl-1,2,4,5-tetrahydro-3-benzazepin-8-ol
- RefChem:930510
- SCH 23390
- UNII-UGT5535REQ
- UGT5535REQ
- R-(+)-SCH-23390
- Sch 23388
- SCH23390
- GOTMKOSCLKVOGG-OAHLLOKOSA-N
- Tocris-0925
- Biomol-NT_000016
- Lopac0_000456
- BPBio1_001173
- orb2945442
- SCHEMBL2916216
- SCH 23390 (R-enantiomer)
- SCHEMBL29424268
- BDBM82247
- CHEBI:92798
- GTPL14202
- (R)-SCH23390
Look up SCH-23390 in the interactive SynDRA portal →